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Aims Membrane potential is a key determinant of vascular tone and many vasodilators act through the modulation of ion
channel currents [e.g. the ATP-sensitive potassium channel (KATP)] involved in setting the membrane potential. Ade-
nylyl cyclase (AC) isoenzymes are potentially important intermediaries in such vasodilator signalling pathways. Vas-
cular smooth muscle cells (VSMCs) express multiple AC isoenzymes, but the reason for such redundancy is
unknown. We investigated which of these isoenzymes are involved in vasodilator signalling and regulation of vascular
ion channels important in modulating membrane potential.
Methods
and results
AC isoenzymes were selectively depleted (by .75%) by transfection of cultured VSMCs with selective short inter-
fering RNA sequences. AC6 was the predominant isoenzyme involved in vasodilator-mediated cAMP accumulation in
VSMCs, accounting for  60% of the total response to b-adrenoceptor (b-AR) stimulation. AC3 played a minor role
in b-AR signalling, whereas AC5 made no signiﬁcant contribution. AC6 was also the principal isoenzyme involved in
b-AR-mediated protein kinase A (PKA) signalling (determined using the ﬂuorescent biosensor for PKA activity,
AKAR3) and the substantial b-AR/PKA-dependent enhancement of KATP current. KATP current was shown to play
a vital role in setting the resting membrane potential and in mediating the hyperpolarization observed upon b-AR
stimulation.
Conclusion AC6, but not the closely related AC5, plays a principal role in vasodilator signalling and regulation of the membrane
potential in VSMCs. These ﬁndings identify AC6 as a vital component in the vasodilatory apparatus central to the
control of blood pressure.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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1. Introduction
Vascular tone is determined by the contractile state of the smooth
muscle cells within the vessel wall and, as such, represents
the balance between vasodilator and vasoconstrictor inﬂuences.
A variety of endogenous vasodilators can act via G protein-coupled
receptors (GPCRs) present in vascular smooth muscle cells
(VSMCs) to mediate vasodilation. Vasodilator-activated GPCRs,
such as b-adrenoceptors (b-ARs), primarily signal through Gs pro-
teins to stimulate cyclic AMP (cAMP) synthesis by adenylyl cyclase
(AC) isoenzymes. Stimulation of cAMP-dependent protein kinase
(PKA) leads to the phosphorylation of a variety of cellular targets,
including the activation of a number of K
+ channels present in
VSMCs, leading to hyperpolarization and vasodilation.
1,2
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doi:10.1093/cvr/cvr137VSMC tone is highly dependent on the membrane potential, which
is principally determined by the activity of K
+ channels. ATP-sensitive
K
+ (KATP) channels, which consist of hetero-octamers of four pore-
forming subunits (encoded by members of the Kir6 family) and four
additional sulphonylurea subunits,
2 are sensitive to the metabolic
status of the cell, being closed by the binding of intracellular ATP.
The KATP channel contributes to the resting membrane potential of
VSMCs, as its pharmacological blockade increases basal tone in
both coronary
3 and systemic
4 circulations. In addition, genetically
modiﬁed mice lacking a functional vascular KATP channel display elev-
ated blood pressure, coronary vasospasm, and sudden death,
5,6
although the vascular basis of this phenotype has been questioned.
7
KATP channel activation by a variety of vasodilators has been
observed,
1 with several reports implicating KATP channel activation in
b-AR-mediated vasodilation in a range of vascular beds.
4,8 Mice
lacking the b2-AR develop hypertension during exercise,
9 whereas
spontaneously hypertensive rats display impaired vascular b-AR
responses,
10andasubsetofhypertensivepatientsexhibitcompromised
b-AR-mediated vasodilation.
11 In addition, single-nucleotide poly-
morphisms in the b2-AR gene are associated with impaired vasodilator
responses to b-AR stimulation.
12 Along with other vasodilator signals,
b-AR activation has been shown to enhance KATP channel activity via
stimulation of PKA, resulting from AC-mediated cAMP generation.
13
TheACfamilycomprisesninemembrane-bound(ACs1–9)andone
soluble(sAC)isoenzymes,eachwithdistinctexpressionandregulatory
proﬁles.
14 In common with most other cell types, VSMCs express mul-
tiple AC isoenzymes, with strongest evidence for ACs 3, 5, and 6.
15–17
Reasons for such apparent redundancy are unclear and little is known
regarding which of these isoenzymes mediate the functional effects of
vasodilator signalling in the vasculature. Previous studies have focused
on AC isoenzyme expression rather than function
16,17 or have
suggested potential vasodilator GPCR-AC isoenzyme functional
coupling based on caveolar co-localization,
15,18 or the recombinant
over-expression of AC isoenzymes.
19
Here, we have investigated the roles of a number of the most highly
expressed AC isoenzymes in b-AR-mediated signalling in VSMCs. Our
ﬁndings indicate that AC6 is the primary endogenous AC isoenzyme
involved in b-AR-mediated cAMP/PKA signalling and activation of
the KATP current, which plays a key role in setting the membrane
potential and thereby regulating vascular tone. In contrast, the
closely related AC5 plays no discernible part in this signalling
cascade in VSMCs, highlighting an important functional distinction
between these two closely related isoenzymes.
2. Methods
2.1 VSMC isolation, culture, and transfection
Adult male Wistar rats (150–400 g) were killed by stunning and cervical
dislocation. The care of animals was in accordance with the UK Animals
(Scientiﬁc Procedures) Act 1986. The investigation also conforms to the
Guide for Care and Use of Laboratory Animals US (NIH Publication
No. 85-23, revised 1996). Dissection and enzymatic digestion was
carried out as previously described for aortic smooth muscle cells.
20
VSMCs were cultured in Dulbecco’s modiﬁed Eagle’s medium (with gluta-
MAX) supplemented with 10% foetal calf serum, 100 IU/mL penicillin,
100 mg/mL streptomycin, and 2.5 mg/mL amphotericin B. Cells were
transfected with short interfering (si)RNA 48 h prior to experimentation
using the Lonza nucleofection device.
2.2 RT–PCR and western blotting
RT–PCR was performed as previously reported
21 for AC1–8 isoen-
zymes. PCR ampliﬁcation was performed using a LightCycler instrument
(Roche Applied Science). Cycling conditions were: 958C (600 s), followed
by 45 cycles of 958C (10 s), 608C (10 s), and 708C (1 s). Data were pre-
sented as DCT [CT (negative-control siRNA-transfected cells) 2 CT
(AC-targeting siRNA-transfected cells)] values. AC3 protein expression
was determined by immunoblotting as described previously.
18 Cell
lysates were electrophoretically separated and transferred to a nitrocellu-
lose membrane. AC3 expression was assessed using a speciﬁc anti-rabbit
polyclonal antibody against AC3 (Santa Cruz Biotechnology, CA, USA)
and detected by the addition of enhanced chemiluminescence-plus
(ECL-plus) reagent (GE Healthcare, UK) and exposure to Hyperﬁlm
(GE Healthcare). Relative protein expression was quantiﬁed using the
GeneGnome image analysis system (Syngene, Cambridge, UK).
2.3 cAMP determination
Cells were pre-incubated with the non-selective phosphodiesterase
(PDE) inhibitor 3-isobutyl-1-methylxanthine (IBMX, 300 mM) for 10 min,
followed by stimulation with agonist for 5 min. Samples were extracted
on ice in 0.5 M TCA and, following neutralization, were assayed for
cAMP by competition assay, as described previously.
22
2.4 Fluorescence resonance energy transfer
experiments
VSMCsexpressingAKAR3constructs
23wereimagedusingaZeissAxiovert
200microscope(CarlZeiss, WelwynGardenCity,UK). Cells wereexcited
at 440 nm and ﬂuorescence resonance energy transfer (FRET) ratios
measured as a change in the ratio of ﬂuorescence intensities at 470 and
535 nm. Images were acquired and processed using MetaFluor software
(Molecular Devices, Downington, PA, USA).
2.5 Electrophysiological experiments
Whole-cell KATP currents from acutely dissociated VSMCs were recorded
at 260 mV (with external K
+ raised to 140 mM) as reported previously.
18
Currents from cultured VSMCs (visually identiﬁed as transfected by eGFP
ﬂuorescence) were recorded at 0 mV using a modiﬁed version of the
technique reported by Yuan et al.
24 All experiments were performed at
30–328C.
2.6 Data analysis and statistics
Dataarepresentedthroughoutasmeans+SEMfromfouror moreexper-
iments obtained in different preparations. Statistical comparisons used
Student’s paired or unpaired t-test or one- or two-way ANOVA followed
by appropriate post hoc testing (GraphPad Prism, San Diego, CA, USA).
See also Supplementary material online for further details of exper-
imental procedures.
3. Results
3.1 Activation of the b-AR hyperpolarizes
VSMCs via KATP activation
In acutely dissociated VSMCs, the mean membrane potential
recorded in whole-cell current clamp under control conditions was
235.1+1.4 mV (n ¼ 8; Figure 1A and B). Stimulation of the endogen-
ous b-AR population with isoprenaline (ISO; 100 nM) caused a sub-
stantial hyperpolarization (to 262.5+3.3 mV; n ¼ 8; Figure 1A and
B), which was reversed on addition of the KATP channel blocker glib-
enclamide (10 mM); indeed, the membrane potential in the presence
of ISO and glibenclamide (222.0+1.5 mV; n ¼ 8) was signiﬁcantly
Role of AC6 in aortic smooth muscle cells 695depolarized relative to control (P , 0.01, one-way ANOVA, Bonfer-
roni’s post hoc test; Figure 1A and B). Similar effects were observed
using the speciﬁc KATP channel opener P1075 (10 mM; Figure 1B).
VSMC resting membrane potential can be inﬂuenced by KATP
channel activity and b-AR activation causes a marked hyperpolariz-
ation by enhancing the KATP current.
We further investigated this by performing whole-cell recordings
of the KATP current in acutely dissociated VSMCs. On switching to
140 mM extracellular K
+ (indicated by the arrow in Figure 1C and
D), spontaneous, glibenclamide-sensitive currents developed, reﬂect-
ing basal KATP channel activity. The magnitude of this current was
not signiﬁcantly altered by pre-incubation with the PKA inhibitor
KT5720 (1 mM) (data not shown). The addition of 100 nM
ISO revealed a substantial increase in the glibenclamide-sensitive
current (increased by 13.2+2.8 pA/pF; n ¼ 6, P , 0.001, two-way
ANOVA, Bonferroni’s post hoc test; Figure 1C and E). In the presence
of the PKA inhibitor, KT5720 (1 mM), the addition of ISO had no
signiﬁcant effect (change in current of 0.8+0.9 pA/pF; n ¼ 6;
Figure 1D and E). Similar data were obtained with another PKA
inhibitor, Rp-cAMPS (100 mM), where the glibenclamide-sensitive
current was unaltered by the addition of ISO (change in current
of 1.1+0.7 pA/pF; n ¼ 5). Endogenous VSMC KATP current is
therefore signiﬁcantly enhanced by b-AR stimulation in a PKA-
dependent manner.
Figure 1 b-AR stimulation hyperpolarizes VSMCs, via activation of KATP current. (A) ISO (100 nM)-mediated hyperpolarization of acutely disso-
ciated VSMCs and its reversal by the KATP channel blocker glibenclamide (10 mM). (B) Mean data for the effects of ISO (100 nM) or the KATP
channel opener P1075 (10 mM) on membrane potential in the absence and presence of glibenclamide (10 mM). (C and D)K ATP current recordings
in response to ISO (100 nM) in the absence (C) and presence (D) of the PKA inhibitor KT5720 (1 mM). The arrow indicates the point at which extra-
cellular K
+ was switched to 140 mM. (E) Mean data for ISO (100 nM)-mediated change in glibenclamide-sensitive KATP current in the absence and
presence of KT5720 (1 mM). Data are expressed as means+SEM from n ≥ 6 cells, from three or more preparations. Statistical signiﬁcance is indi-
cated as *P , 0.05, **P , 0.01, and ***P , 0.001 vs. basal;
‡‡‡P , 0.001 for ISO/P1075+glibenclamide.
C.P. Nelson et al. 6963.2 Endogenous AC expression and
siRNA-mediated knockdown in VSMCs
Due to a lack of suitably selective antibodies for many of the AC
isoenzymes, we investigated the AC expression proﬁle in VSMCs by
RT–PCR. Mean cycle threshold (CT) values are presented for tran-
scripts corresponding to AC1–8, indicating relatively high transcript
levels of AC3 and 5–7 in acutely dissociated VSMCs (Table 1).
A broadly similar proﬁle was observed in SMCs acutely isolated
from the mesenteric arteries (data not shown), a resistance arterial
bed. In VSMCs maintained in culture for between three and six pas-
sages, CT values corresponding to AC3 and 5–7 again indicated that
these transcripts are expressed at high levels in cultured VSMCs,
although there was some indication that AC2 and 8 transcripts
were higher in passaged VSMCs (Table 1).
siRNA sequences designed speciﬁcally to target AC3, 5, 6, or a
negative-control (scrambled) sequence were transfected into
VSMCs, using the Lonza nucleofection system, to obtain high
(.90%) levels of transfection efﬁciency with siRNA (see Supplemen-
tary material online, Figure S1). AC isoenzymic expression was
assessed 48 h later by RT–PCR (Figure 2). AC3 expression was
suppressed in the presence of AC3-targeting siRNA (DCT ¼ 23.2),
whereas AC5–7 were unaffected (Figure 2A–D). Similarly, levels of
AC5 and 6 were selectively reduced by their respective siRNA
sequences (Figure 2A–D). siRNA-mediated suppression of AC3
could be conﬁrmed at the protein level, by immunoblotting with
an AC3-speciﬁc antibody (Figure 2E). The mean AC3 expression in
....................................................................................
Table 1 AC expression in VSMCs
AC isoenzyme Acutely dissociated VSMCs Cultured VSMCs
1 42.5+1.6 (5) 37.1+0.7 (6)
2 37.8+2.7 (5) 29.0+ + + + +0.1 (6)
3 28.9+ + + + +1.1 (5) 24.4+ + + + +0.4 (7)
4 35.1+1.1 (5) 36.1+1.3 (6)
5 28.4+ + + + +0.6 (5) 29.7+ + + + +0.6 (7)
6 26.7+ + + + +0.6 (5) 26.8+ + + + +0.6 (7)
7 26.5+ + + + +0.7 (4) 24.2+ + + + +0.7 (6)
8 40.7+3.0 (5) 28.5+ + + + +0.8 (6)
RT–PCR for AC isoenzyme expression in acutely dissociated and cultured VSMCs.
Data are expressed as mean cycle threshold (CT) values+SEM from four or more
separate preparations (number indicated in parentheses). Highly expressed (CT value
,30) isoenzymes are highlighted in bold.
Figure 2 siRNA-mediated knockdown of AC isoenzymes in VSMCs. AC3 (A), AC5 (B), AC6 (C), and AC7 (D) expression was assessed by RT–PCR
in cells transfected with siRNA sequences targeting ACs 3, 5, or 6 alone or in combination. Data are expressed as mean DCT [CT (negative-control
siRNA-transfected cells) 2 CT (AC-targeting siRNA-transfected cells)] values+SEM from four or more samples. Negative DCT values indicate a
depletion of AC isoenzyme mRNA. (E) Immunoblot demonstrating AC3 protein depletion in VSMCs transfected with AC3-targeting siRNA, repre-
sentative of four similar experiments.
Role of AC6 in aortic smooth muscle cells 697cells transfected with AC3-targeting siRNA was reduced to 16+8%
of that in negative-control siRNA-transfected VSMCs (P , 0.05,
Student’s unpaired t-test; n ¼ 4).
3.3 The role of AC isoenzymes in cAMP
signalling in VSMCs
Stimulation of endogenous b-ARs with ISO (1 mM) elicited a robust
increase in cAMP in VSMCs. Experiments conducted in the presence
or absence of the b1- (CGP20712A, 100 nM) and b2-selective
(ICI118551, 100 nM) antagonists demonstrated that the majority of
the cAMP response to ISO was mediated by a b2-AR population
(see Supplementary material online, Figure S2A). In AC3/5/6-depleted
VSMCs, levels of cAMP produced by either direct AC activation
with forskolin (10 mM) or b-AR activation by ISO (1 mM) in each
case in the presence of the PDE inhibitor IBMX (300 mM) were sub-
stantially reduced (by 70–75%; Figure 3A). Basal cAMP levels were
not signiﬁcantly decreased (Figure 3A). ISO-mediated cAMP
responses were smaller in the absence (328+106 pmol/mg
protein; n ¼ 4) than in the presence (939+243 pmol/mg protein;
n ¼ 7) of IBMX and AC3/5/6 depletion almost completely abolished
the response to ISO (40+15 pmol/mg protein; n ¼ 4) in the
absence of IBMX (data not shown). However, as a result of the
greater consistency and signal to noise achieved, all subsequent
cAMP measurements were performed in the presence of IBMX
(300 mM). In AC3/5/6-depleted VSMCs, ISO-mediated cAMP
accumulation was substantially attenuated across a range of concen-
trations, with no change in potency (see Supplementary material
online, Figure S2B).
In AC6-depleted cells, responses to forskolin were reduced to 41%
of control, whereas depletion of AC3, and to a lesser extent AC5,
also signiﬁcantly attenuated cAMP accumulation (Figure 3B). A
similar proﬁle was observed for ISO-mediated cAMP responses,
with AC6 the principal isoenzyme mediating the response to b-AR
stimulation (42% of control response in AC6-depleted cells;
Figure 3C). However, although AC3 depletion signiﬁcantly reduced
the response (to 70% of control), AC5 depletion had no statistically
signiﬁcant effect on b-AR-mediated cAMP accumulation (Figure 3C).
Responses to the (Gs-coupled) vasodilators CGRP, PACAP, ilo-
prost, and PGE2 alone were too small to allow accurate assessment
of the roles of individual AC isoenzymes (data not shown).
However, in the presence of a very low level of forskolin (0.1 mM),
which itself caused only a modest cAMP response (from 31+13 in
control to 96+26 pmol/mg protein in the presence of forskolin;
n ¼ 4), each agonist stimulated enhanced cAMP responses (see Sup-
plementary material online, Figure S2C), as has been previously
demonstrated.
25 ISO-stimulated cAMP accumulation was highly sensi-
tive to AC6 depletion in either the absence or presence of forskolin
(0.1 mM) (see Supplementary material online, Figure S2C). A similar
proﬁle was observed for each of the other four vasodilators investi-
gated (see Supplementary material online, Figure S2C). AC6, therefore,
seems to be the primary isoenzyme involved in vasodilator-mediated
cAMP signalling in vascular smooth muscle.
Although depletion of AC3/5/6 together substantially reduced
forskolin- and ISO-mediated cAMP signalling (by 87 and 77%,
respectively; Figure 3), it is possible that the residual responses
were mediated by alternative AC isoenzymes. In our earlier PCR
screen, the AC7 transcript appeared to be present at similar
levels to AC3/5/6 (Table 1). We therefore validated an siRNA
targeting AC7 (see Supplementary material online, Figure S3A). In
VSMCs transfected with this siRNA sequence, forskolin- and ISO-
mediated cAMP responses were not reduced and, in fact, were
slightly enhanced (see Supplementary material online, Figure S3B).
AC7 does not, therefore, appear to play a signiﬁcant role in
b-AR-mediated cAMP signalling in VSMCs.
Figure 3 AC6 is the predominant isoenzyme mediating
b-AR-stimulated cAMP accumulation in VSMCs. Mean cAMP
accumulations in VSMCs transfected with negative-control siRNA
or siRNA sequences targeting ACs 3, 5, or 6 (alone or all three in
combination) and stimulated with forskolin (10 mM) (A and B)o r
ISO (1 mM) (A and C). Data are presented as mean cAMP (pmol/
mg protein) (A) or as a percentage of the response in cells trans-
fected with negative-control siRNA (B and C). Data are expressed
as means+SEM from n ≥ 5 experiments, from three or more sep-
arate cultures. Statistical signiﬁcance is indicated as **P , 0.01 and
***P , 0.001 vs. control.
C.P. Nelson et al. 6983.4 AC6 is essential for b-AR-mediated
PKA signalling in VSMCs
We utilized a FRET-based biosensor for PKA activity (AKAR3
23)t o
examine the role of individual AC isoenzymes in ISO-mediated PKA
signalling. Brief (60 s) stimulation of AKAR3-transfected VSMCs with
ISO (100 nM) elicited a rapid and reversible increase in the FRET
ratio (Figure 4A and B). In contrast, in cells expressing a negative-
control version of AKAR3 (AKAR3 T/A), application of ISO
(100 nM) failed to alter signiﬁcantly the FRET ratio (Figure 4A and
B). In AC6 (Figure 4D and F) or AC3/5/6 (Figure 4E and F) depleted
VSMCs, AKAR3 responses to either 10 or 100 nM ISO were
signiﬁcantly attenuated, relative to control siRNA-transfected cells
[Figure 4C and F; P , 0.01 (AC6, 10 nM ISO); P , 0.05 (AC6,
100 nM ISO); P , 0.001 (AC3/5/6, 10 or 100 nM ISO); one-way
ANOVA, Bonferroni’s post hoc test]. Depletion of AC6 or AC3/5/6
had similar effects on the AKAR3 responses to ISO, suggesting
that in agreement with our data for cAMP signalling, AC6 is the key
cAMP-synthesizing isoenzyme for b-AR-mediated PKA activation.
Figure 4 The role of AC isoenzymes in b-AR-mediated PKA activation in VSMCs. Representative traces (A) and mean data (B) for changes in the
FRET ratio in response to ISO (100 nM) in VSMCs transfected with AKAR3 [black trace (A) and open bar (B)] or AKAR3 T/A [grey trace (A) and
closed bar (B)]. Data are expressed as mean normalized FRET ratio (A) or percentage change in the FRET ratio over baseline (DFRET, B)+SEM
from n ≥ 10 cells from three separate cultures. (C–E) Changes in the FRET ratio in response to ISO (10 or 100 nM, as indicated) in VSMCs transfected
with AKAR3 and either negative-control (C), AC6-targeting (D), or AC3/5/6-targeting (E) siRNA sequences. (F) Mean data for the per cent changes in
the FRET ratio above baseline (DFRET) in VSMCs transfected with AKAR3 and siRNA sequences. Data are expressed as means+SEM from ≥38 cells
taken from three different cultures. Statistical signiﬁcance is indicated as *P , 0.05, **P , 0.01, and ***P , 0.001 vs. AKAR3 (B) or control (F)
responses.
Role of AC6 in aortic smooth muscle cells 6993.5 AC6 is the principal isoenzyme
mediating b-AR-KATP channel modulation
in VSMCs
To examine the roles of AC isoenzymes in b-AR-mediated KATP
channel modulation, we characterized the KATP current in cultured
VSMCs, measuring P1075-, ISO-, and metabolic inhibition-induced
current and membrane potential changes (see Supplementary
material online, Figure S4). We also conﬁrmed that ISO had similar
PKA-dependent effects on KATP current and membrane potential in
cultured VSMCs as in acutely dissociated cells (see Supplementary
material online, Figure S5). In untransfected (data not shown) or
negative-control siRNA-transfected (Figure 5A and F) VSMCs, ISO
(100 nM) caused a robust increase in current (from 0.47+
0.07 pA/pF in control to 5.99+0.45 pA/pF in the presence of ISO;
n ¼ 16), which was glibenclamide-sensitive (0.06+0.05 pA/pF
remaining in the presence of the KATP blocker). Depletion of AC3
reduced the response to ISO by 34% (P , 0.01, two-way ANOVA
and Bonferroni’s post hoc test; Figure 5B and F), whereas knockdown
of AC5 was without signiﬁcant effect (Figure 5C and F). AC6 depletion
had the largest effect, with ISO-mediated enhancement of KATP
channel activity reduced by 74% relative to control-transfected cells
(P , 0.001; two-way ANOVA and Bonferroni’s post hoc test;
Figure 5D and F). Depletion of AC3/5/6 reduced the ISO response
by  95% (P , 0.001; two-way ANOVA and Bonferroni’s post hoc
test; Figure 5E and F). In contrast, basal KATP current and that initiated
by the KATP channel opener P1075 were unaffected by the knock-
down of these AC isoenzymes, singly or in combination (Figure 5).
b-AR-mediated modulation of KATP channel activity in VSMCs is
therefore highly dependent on AC6 (and to a lesser extent AC3)
activity, whereas AC5 plays no signiﬁcant role.
4. Discussion
We have shown in VSMCs that AC6 plays a critical role in
b-AR-mediated signalling. The activation of this signalling pathway
elicits a substantial hyperpolarization (by ≥27 mV) of VSMCs
through the sequential activation of AC6, PKA, and KATP current.
Since the relationship between membrane potential and contractile
tone in VSMCs is an extremely steep one, such a change in membrane
potential would be expected to elicit a signiﬁcant change in arterial
diameter. This pathway is therefore a critical determinant of both
blood pressure and blood ﬂow to organs.
KATP channels have been previously demonstrated to contribute to
the regulation of vascular tone. Genetic disruption of the pore-forming
Kir6.1 subunit in mouse causes elevated blood pressure, a Prinzmetal
angina-likephenotypeandasensitivitytovasoconstrictors.
5Inaddition,
b-ARsignallinginitiatesVSMChyperpolarizationviaAC/PKAactivation
and the opening of KATP channels.
26,27 We have conﬁrmed that in
VSMCs, ISO-mediated stimulation of the b-AR (predominantly
b2-AR) population elicited a robust, PKA-dependent increase in KATP
current, which developed with a 20–30 s delay consistent with the
onset of PKA activation in our system (Figure 4). These observations,
together with the fact that glibenclamide fully reversed ISO-mediated
hyperpolarization, indicate that KATP channels are a physiologically
important target of the Gas/AC/cAMP/PKA signalling pathway, both
at rest and during vasodilation.
In common with earlier studies,
15–17 we found evidence, at the
mRNA level, for expression of multiple AC isoenzymes in VSMCs.
Taking these ﬁndings as a whole, it is clear that mRNAs for AC3,
5, and 6 consistently appear to be most highly expressed, and for
this reason, we focused on these isoenzymes in the majority of our
subsequent investigation. Indeed, depletion of AC3, 5, and 6
together was highly effective in attenuating the cellular cAMP
response to ISO (by .75% in the presence and  90% in the
absence of IBMX) and several other vasodilators. We therefore
believe that it is unlikely that any additional AC isoenzyme has a
signiﬁcant functional role in vasodilator-mediated cAMP generation
in VSMCs.
We provide evidence for a modest, but signiﬁcant role for AC3 in
both forskolin- and ISO-mediated signalling in VSMCs. AC3 is
reported to be the principal AC isoenzyme activated by PGE2 in
VSMCs,
28 with PGE2-mediated cAMP responses being attenuated by
Figure 5 AC6 is the predominant isoenzyme mediating the
b-AR-stimulated KATP current in VSMCs. KATP current recordings
in VSMCs transfected with negative control (A), AC3 (B), AC5 (C),
AC6 (D), or AC3/5/6 (E)-targeting siRNA sequences. Cells were
held at 0 mV and P1075 (10 mM), ISO (100 nM), and glibenclamide
(10 mM) were added as indicated. (F) Mean glibenclamide-sensitive
current values (normalized to cell capacitance) in VSMCs transfected
with negative-control or AC-targeting siRNA sequences. Data are
expressed as means+SEM for n ≥ 8 cells, from three separate cul-
tures. Statistical signiﬁcance is indicated as **P , 0.01 and
***P , 0.001 vs. control.
C.P. Nelson et al. 700 50% in mice heterozygous for the disrupted AC3 gene. Our ﬁndings
(and those by Ostrom et al.
15) indicate a more minor role for AC3 in
PGE2-mediated cAMP signalling (see Supplementary material online,
Figure S2C), perhaps suggesting species-speciﬁc differences in the
roles of AC isoenzymes. However, AC3 has also been shown to
play a signiﬁcant role in Ca
2+-stimulated rat VSMC cAMP signalling,
15
providing further evidence for its functional expression in this tissue.
Perhaps, the most surprising ﬁnding of our study was the striking
difference in the relative importance of AC5 and AC6 isoenzymes
in VSMCs. AC5 and AC6 display a high level of homology in amino
acid sequence (65%) and share many regulatory properties,
14 so the
dominant role of AC6 and the apparent absence of a signiﬁcant
role for AC5 in b-AR-mediated cAMP signalling in aortic cells are
intriguing results. This selectivity does not appear to be peculiar to
b-AR signalling, as a panel of alternative vasodilators displayed a
similar AC6 dependence. In support of a central role for AC6 in vaso-
dilator signalling, Ostrom et al.
15 found that modest (approximately
two-fold) over-expression of AC6 in VSMCs enhanced forskolin-,
ISO-, and PGE2-mediated cAMP signalling. A further study in
VSMCs found that AC6 over-expression enhanced ISO-mediated
morphological change (which has been related to vasodilator reactiv-
ity), as well as forskolin-stimulated vasodilator-stimulated phospho-
protein phosphorylation (an index of PKA activity).
19 These ﬁndings
are consistent with a predominant role for AC6 in vasodilator/PKA
signalling, but are limited by their reliance on over-expression. siRNA-
mediated depletion of both AC5 and AC6 in VSMCs has been shown
to attenuate uridine diphosphate-mediated inhibition of ISO-
stimulated cAMP signals.
29 This was considered as correlative evi-
dence that b-AR may couple preferentially to endogenous AC5/6.
29
However, puzzlingly the ISO response was not reduced per se in
the AC5/6-depleted cells. These studies hint at the involvement of
AC5/6, whereas our ﬁndings demonstrate the principal role for
AC6 in vasodilator signalling in VSMCs.
Although our study has focused on deﬁning the relative importance
of AC isoenzymes, it must be noted that PDE isoenzymes also exhibit
considerable diversity and compartmentalization. The functional com-
partmentalization of distinct PDE isoenzymes (particularly PDE3 and
PDE4) has previously been reported to inﬂuence the differential acti-
vation of PKA and PKG following b-AR activation in the rat aorta.
30 It
is therefore possible that different PDEs, perhaps co-located with
speciﬁc AC isoenzymes, also play a critical role in regulating local or
global cAMP levels.
The absence of a signiﬁcant role for AC5 in vasodilator signalling in
the vasculature could potentially be of clinical relevance. AC5 inhi-
bition, or genetic disruption, is well established to be cardioprotective
in mice exposed to chronic pressure overload
31 and to enhance long-
evity,
32 leading to the suggestion that its inhibition might provide an
effective treatment for congestive heart failure (CHF).
33 An obvious
problem with such a strategy would be that AC5 is not expressed
exclusively in the heart, with off-target effects in the vasculature
being cited as a potential problem.
33 However, in light of our ﬁndings
(albeit presently limited to aortic smooth muscle cells), it is possible
that any such side effects would be minimal, provided that any poten-
tial agent was highly selective for AC5 over AC6.
In contrast, AC6 over-expression in cardiac tissue improves func-
tion and may be beneﬁcial in the failing heart,
34,35 leading to the
notion that intracoronary AC6 gene transfer might be a rational
approach to CHF therapy.
36 If AC6 is a key determinant of vasore-
laxation, might its over-expression/activation in the vasculature also
be beneﬁcial? Enhancing vasodilation in CHF would reduce afterload
and myocardial oxygen consumption (while perhaps increasing coron-
ary blood supply), which might be anticipated to improve cardiac
function. A single-nucleotide polymorphism in the b2-AR (Ile164),
which results in reduced AC coupling, is associated with an increased
relative risk of death
37 as well as a decreased exercise capacity and
vasodilatory response to exercise
38 in CHF patients. Although
results contradictory to these have been reported,
12 these obser-
vations suggest that augmented vasodilation might indeed be protec-
tive in CHF. If AC6 expression/activity is the limiting factor in
vasodilator signalling, as is suggested by previous studies,
15,39 the poss-
ible beneﬁcial effects of enhancing AC6 activity in vascular smooth
muscle are worthy of further investigation.
The principal importance of AC6 in vascular smooth muscle
physiology is highlighted by our demonstration of the dependence
of b-AR-mediated PKA signalling and PKA-dependent KATP modu-
lation on the expression of this isoenzyme. KATP channel activity,
which we and others have established as a key determinant of
the membrane potential, is substantially increased by b-AR acti-
vation, predominantly via AC6-mediated cAMP generation and
PKA activation. This identiﬁes AC6 as a vital regulator of vascular
tone, with implications for cardiovascular function in both health
and disease.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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